HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Urgent call for global strategies and resources to confront the rapid "feminization" of the AIDS pandemic

In an article appearing in the journal Science online June 10, Thomas C. Quinn, M.D., professor of infectious diseases at Hopkins and a senior investigator at the National Institute of Allergy and Infectious Disease, reports that women have in the last 20 years moved from those least affected by HIV to those in whom the disease is spreading fastest.

10 Jun 2005

Similarities in antiretroviral therapy efficacy in poorer countries to that in industrial nations

Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.

9 Jun 2005

Several minute intermediate stage in virus-cell fusion may represent a window of opportunity for drug development

To ignite a life-threatening infection in the body, a virus such as HIV invades body cells by first merging, or fusing, with the cell's outer membrane. Once inside the cell, the invading microbe's genetic material takes over, turning the 'host' cell into a factory to produce more copies of the virus, which then spill out to invade other cells in the body.

8 Jun 2005

Home test kits provide young women with a safe and effective means for protecting their sexual reproductive health

Researchers at Johns Hopkins say they have evidence that more than one-third of young women are willing and able to use a free, easily available home test kit to privately and accurately learn if they are infected with Chlamydia trachomatis, the most common sexually transmitted disease (STD) in this group.

8 Jun 2005

Prototype drug shows promise in slowing replication of the virus responsible for SARS

A prototype drug created by researchers at the University of Illinois at Chicago shows promise in slowing replication of the virus responsible for severe acute respiratory syndrome, or SARS.

8 Jun 2005

Tuberculosis now a worldwide threat

The Journal of the American Medical Association (JAMA) says that Tuberculosis (TB) is on the rise throughout the world and new cases among immigrant populations demands increased attention and funding.

7 Jun 2005

UN warns of the losing battle in world AIDS fight

UN officials are saying that their goal of containing the AIDS pandemic by 2015 may now be unrealistic because the spread of the disease is outpacing the efforts of many countries to prevent it.

5 Jun 2005

International action needed on health in Turkmenistan

Health experts called on the international community to put pressure on the Turkmenistan government to improve health and stop human rights abuses.

3 Jun 2005

Progress on HIV/AIDS significant but insufficient

United Nations Secretary-General Kofi Annan today shared his hope with a gathering of senior world officials at Headquarters that the 2001 Declaration of Commitment on HIV/AIDS would have heralded a response that matched the epidemic’s scale, yet progress had been “significant but insufficient”.

3 Jun 2005

HIV protease inhibitors block programmed cell death in vivo

The immunodeficiency that arises in HIV may be due to excessive programmed cell death of immune CD4 T cells.

3 Jun 2005

HIV/AIDS drugs may also be effective against malaria

Researchers at The Queensland Institute of Medical Research (QIMR) have found that drugs used to treat HIV Aids may also be effective against the biggest killer in the world - malaria.

2 Jun 2005

Indian drug company Ranbaxy gains FDA approval for HIV drug

Indian drug company Ranbaxy Laboratories has this week become the first Indian drug company to gain regulatory approval for a generic anti-HIV drug.

2 Jun 2005

A drug used to prevent mother-to-child transmission of HIV-1 induces resistance more often than previously thought

The incidence of drug resistance associated with single-dose nevirapine, a drug used to prevent mother-to-child transmission of HIV-1, may be substantially higher than previously thought and of particular risk for those infected with HIV-1 subtype C, according to three new studies published in the July 1 issue of The Journal of Infectious Diseases, now available online.

1 Jun 2005

Go-ahead for HIV computer game

A ground breaking computer game developed by a University of Salford lecturer to help educate young South Africans about the dangers of HIV and AIDS will be piloted in July.

1 Jun 2005

HIV deaths drop 90 percent among African-American IDUs who are given access to combination drug therapy

Combination drug therapy effectively reduces 90 percent of HIV deaths in African-American injection drug users when they are given ample access to care, according to a new Academy study in the June issue of the American Journal of Epidemiology.

1 Jun 2005

Study of compassionate care

Patients approaching the end of life can significantly reduce their depression symptoms and improve their sense of spiritual well-being according to a study published in the current issue of the Journal of Palliative Medicine.

1 Jun 2005

Interaction between cell and virus provides scientists valuable insights into the development of safe viral vectors for use in oncology

When infected by a virus, a cell uses specific defense mechanisms developed in the course of a long evolution. Thus, it can activate enzymes that disrupt or prevent replication of the viruses within the cell.

1 Jun 2005

African HIV subtypes identified in Minnesota

Public health researchers in Minnesota recently identified 83 persons infected with subtypes of HIV-1 that are not common in the United States, according to a report published in the June 15 issue of The Journal of Infectious Diseases, now available online.

31 May 2005

Over 3,000 lives lost because of blood bungle by Canadian Red Cross

The Canadian Red Cross has pleaded guilty to distributing contaminated blood supplies. Since getting the tainted blood in the 1980s thousands of Canadians with HIV and hepatitis C were infected and more than 3,000 people have died.

31 May 2005

Survey shows sexual health important component of overall well being for midlife and beyond

Sexual health is an essential element of the quality of life of adults 45+. AARP's recent study, Sexuality at Midlife and Beyond, updates an AARP survey from 1999, and confirms that relationships and sexuality remain at least as important, if not more so, than almost six years ago.

30 May 2005

HIV/AIDS News and Research

Further Reading

Urgent call for global strategies and resources to confront the rapid "feminization" of the AIDS pandemic

Similarities in antiretroviral therapy efficacy in poorer countries to that in industrial nations

Several minute intermediate stage in virus-cell fusion may represent a window of opportunity for drug development

Home test kits provide young women with a safe and effective means for protecting their sexual reproductive health

Prototype drug shows promise in slowing replication of the virus responsible for SARS

Tuberculosis now a worldwide threat

UN warns of the losing battle in world AIDS fight

International action needed on health in Turkmenistan

Progress on HIV/AIDS significant but insufficient

HIV protease inhibitors block programmed cell death in vivo

HIV/AIDS drugs may also be effective against malaria

Indian drug company Ranbaxy gains FDA approval for HIV drug

A drug used to prevent mother-to-child transmission of HIV-1 induces resistance more often than previously thought

Go-ahead for HIV computer game

HIV deaths drop 90 percent among African-American IDUs who are given access to combination drug therapy

Study of compassionate care

Interaction between cell and virus provides scientists valuable insights into the development of safe viral vectors for use in oncology

African HIV subtypes identified in Minnesota

Over 3,000 lives lost because of blood bungle by Canadian Red Cross

Survey shows sexual health important component of overall well being for midlife and beyond

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News